A cancer diagnosis for a beloved family dog is heart-wrenching. Not all lymphomas are the same, however, and prognoses differ for each.

The U.S. Food and Drug Administration (FDA) has granted a regenerative medicine advanced therapy designation to MB-105, a CD5 ...

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...

AbbVie just scored a major regulatory win at home base. The company’s cancer drug Epkinly has been cleared by the U.S. Food ...

The UK is seeing an increase in Hodgkin lymphoma cases, and forecasts indicate this upward trend will persist without ...

In June 2024, EPKINLY monotherapy was granted accelerated approval by the FDA for the treatment of R/R FL following two or more lines of systemic therapy. With the results from the confirmatory Phase ...